Moderna pharmaceutical company is set to receive “go ahead ” for its newly developed “bivalent” covid booster shot that targets both the original virus and omicron strain. The authorization which is expected to be given to them by the U.S. Food and Drug Administration is still on the waiting list despite the pharmaceutical company releasing […]
